Haemophilia A
Treatment of Haemophilia A by Replacement Therapy using Factor VIII Inhibitors
... Epidemiology. Haemophilia A is an x-linked medical disease which is triggered due to deficiency or deprivation of clotting ...by Haemophilia A with the approximate ratio of 1:5000 male ...of ...
7
Genetic analysis of haemophilia A in Bulgaria
... marker St14 will raise the overall informativeness up to 94%, nevertheless, the risk of recombination between extragenic marker and disease locus may become signifi- cant depending on the number of meioses in question. ...
7
Acquired Haemophilia A Therapeutic Challenge
... Acquired Haemophilia A Therapeutic Challenge Acquired Haemophilia A Therapeutic Challenge utic A Teh, MRCP* K W Leong, MRCP* J J Bosco, FRACP* P L Koong** S Jayaranee, MParh** * Division of Haematolog[.] ...
5
Serum Concentrations of Vitamin D, Calcium, Phosphorus and Trace Minerals in Adults and Children with Haemophilia A: Association with Disease Severity, Quality of Life, Joint Health and Functional Status
... with haemophilia A assessed for the eligibility 4 were excluded because of withdraw consents (n=1) and not meeting inclusion criteria ...85 haemophilia A patients who were enrolled, 27 were under 18 years ...
16
Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee
... Recombinant porcine factor VIII (rpFVIII, Obizur) is not licensed for treatment of congenital haemophilia A. However, if the porcine inhibitor is low, treatment of bleeding episodes with rpFVIII can be considered ...
6
How to discuss gene therapy for haemophilia? A patient and physician perspective
... ongoing haemophilia GT trials utilise the process of gene addition, that is, infusing a hea thy copy of a c otting factor gene VIII or IX via an AAV vector into a patient without a tering their own DNA There is at ...
14
Blood borne virus infection and immune modulation in boys with haemophilia A
... with haemophilia A and to treat them with only one factor VIII ...of haemophilia (Schimpf et al ...the haemophilia service and the coordination of follow ...
403
Haemophilia A: health and economic burden of a rare disease in Portugal
... severe haemophilia A who are exposed to factor VIII concentrates will de- velop neutralizing anti-factor VIII antibodies (inhibi- tors), making clotting factor replacement therapy ineffective ...of ...
11
Genotyping of Intron 22 and Intron 1 Inversions of Factor VIII Gene Using an Inverse-Shifting PCR Method in an Iranian Family with Severe Haemophilia A
... Currently, the Inv22 can be detected either by Southern blot analysis or by long- distance PCR (LD-PCR) (9). Given the short comings of these detection methods, a new system for Inv22 analysis can be IS- PCR that is used ...
8
Prevention of lives affected by haemophilia : a mixed methods study of the views of adults with haemophilia and their families towards genetic screening
... The study explores their attitudes toward, and actual/anticipated uses of, prenatal testing, carrier testing, and selective pregnancy termination for hemophilia, but also their perceptio[r] ...
19
A STUDY OF HAEMOPHILIA IN MAHARASHTRA
... Early diagnosis avoids irreversible arthropathic changes and reduces the frequency of life threatening bleeds in patients with severe FVIII deficiency. In developed nations majority of the severe patients are diagnosed ...
15
Clinical Profile of Haemophilia In Children in A Tertiary Care Hospital
... of haemophilia were ...were haemophilia A and 10 (20%) cases were Haemophilia ...the Haemophilia A, ...the Haemophilia B, 40% cases had mild, 50% cases had moderate and 10% cases had ...
7
HAEMOPHILIA: AN OVERVIEW
... of haemophilia, haemophilia A due to not enough clotting factor VIII and haemophilia B due to not enough clotting factor ...while haemophilia B affects about 1 in 40,000, males at ...
10
Barriers and perceived limitations to early treatment of hemophilia
... The cost effectiveness of a new formulation of recombinant factor VIIa in the home treatment of mild to moderate bleeding episodes in haemophilia A patients with inhibitors in the Unit[r] ...
8
Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency
... Group. Intestinal surgery with activated recombinant factor VII prophy- laxis in patients with haemophilia A and high responding inhibitors: a report of five cases. Blood Coagul Fibrinolysis. 2004;15(8):687–691. ...
13
Inhibitor development in non-severe haemophilia across Europe
... of haemophilia treatment, especially in severe haemophilia ...severe haemophilia A and 5-10% of patients with severe haemophilia B develop inhibitors(6-8) ...
17
Choosing and using non-steroidal anti-inflammatory drugs in haemophilia
... Haemophilia A and B are characterised by bleeding, primarily into joints and muscles. Joint bleeding accounts for >90% of all serious bleeding episodes in person with haemophilia (PWH)[1]. Primary ...
29
The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease
... to haemophilia, with total lifetime costs of ...of haemophilia, haemophilia B being five times less frequent than haemophilia A and the proportion of severe haemophilia A patients being ...
9
The cost of severe haemophilia in Europe: the CHESS study
... of haemophilia A patients relative to that of haemo- philia B in the CHESS cohort (approximately ...between haemophilia A and B is a topic of ongoing research; current evidence suggests that any ...
8
Complications of haemophilia therapy
... infected haemophilia cohort of the Royal Free Hospital Haemophilia Centre Stored serum samples from 525 haemophilia patients registered at the Royal Free Hospital haemophilia centre were first ...
201